Free Trial
NASDAQ:CDIO

Cardio Diagnostics 11/13/2023 Earnings Report

Cardio Diagnostics logo
$3.64 +0.14 (+4.00%)
Closing price 08/21/2025 03:59 PM Eastern
Extended Trading
$3.68 +0.03 (+0.96%)
As of 08/21/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardio Diagnostics EPS Results

Actual EPS
-$5.10
Consensus EPS
-$11.70
Beat/Miss
Beat by +$6.60
One Year Ago EPS
N/A

Cardio Diagnostics Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cardio Diagnostics Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cardio Diagnostics Earnings Headlines

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Update
Washington Thinks They Own Your Bank Account
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.tc pixel
Cardio Diagnostics (NASDAQ:CDIO) Upgraded at Wall Street Zen
Cardio Diagnostics Holdings, Inc. (CDIOW) - Yahoo Finance
See More Cardio Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cardio Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardio Diagnostics and other key companies, straight to your email.

About Cardio Diagnostics

Cardio Diagnostics (NASDAQ:CDIO) develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

View Cardio Diagnostics Profile

More Earnings Resources from MarketBeat